This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Oxygen-dependent mechanisms

Authoring team

Phagocytosis prompts a rapid respiratory burst with activation of the enzyme glucose-6-phosphate dehydrogenase: the hexose monophosphate shunt pathway. Subsequently, the enzyme NADPH oxidase, situated on the inside of the phagolysosome, reduces oxygen to the superoxide ion in tandem with reduction of NADPH. The superoxide ion is capable of killing by means of its reactivity. Alternatively, it is converted by the enzyme superoxide dimutase into toxic hydrogen peroxide. When present, the enzyme myeloperoxidase may further convert hydrogen peroxide to a halogen derivative e.g. HOCl when chloride ions are present. This is an extremely potent oxidant and antimicrobial.

Neutrophils and blood monocytes both contain and use the myeloperoxidase enzyme. Mature macrophages may be able to produce sufficiently toxic levels of radicals without needing the myeloperoxidase enzyme, which they do not possess.

There is a cytoplasmic system to neutralize any hydrogen peroxide which leaks from the phagolysosomes. The enzymes glucose-6-phosphate dehydrogenase, glutathione reductase and glutathione peroxidase detoxify to water.

Defects in each of the enzymes listed can have serious effects in terms of ability to defend against microbes; the most important are:

  • chronic granulomatous disease
  • myeloperoxidase deficiency
  • leukocyte glucose-6-phosphate dehydrogenase deficiency

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.